Hints and tips:
Related Special Reports
...Italian bakery company Forno D’Asolo to a rival buyout group....
...The manifesto called for “radical new action” to address key challenges, such as the need for more investment in creative R&D and reversing the decline in access to creative education as well as a revised...
...To be evaluated, companies must submit their products’ complete R&D documentation and code....
...Companies whose R&D claims have been rejected unexpectedly have been forced to change their business plans....
...at which loss-making companies are taxed within the merged scheme from 25 per cent to 19 per cent and lower the threshold for the additional support for R&D intensive lossmaking firms....
...Nemer said committing to funding levels of $10bn-$15bn for R&D would be justified to tackle other pathogens....
...In the last fiscal year, Apple spent twice as much buying back its own shares as it did on R&D....
...The company spent €6.7bn on R&D last year. It plans to spend an additional €700mn next year. That is not eye-popping. Sanofi’s R&D spend last year was 15.6 per cent of revenues....
...“Although our R&D budget fell this year, we will provide utmost support for R&D spending next year, reflecting the reform results.”...
...But analysts at Jefferies said that worries about the company’s “R&D productivity will take time to lift”, pointing to a lack of significant trial results expected in 2024 and growth tailing off for the...
...“I think something that I should have explained better at earnings was that almost all of the increase in investment in R&D is in D. Because that’s where the action is for us....
...“We employ a consultancy to do our R&D claims for us because we haven’t got the time to fight the claims,” he said....
...AstraZeneca has invested heavily in R&D under Soriot’s tenure and has launched a string of blockbuster products including top-selling cancer drugs Tagrisso and Imfinzi, which brought in $1.6bn and $1.1bn...
...Knocking down long-standing barriers to cross-border trade, making it easier to capture the opportunity of global economic growth through trade deals, better leveraging our capabilities in R&D and ensuring...
...According to the European Federation of Pharmaceutical Industries and Associations, a Brussels-based lobby group, the US attracted a third more R&D investment than Europe in 2010....
...Being big also means that necessary investments, in new models and R&D, are less of a drag. Capex and R&D will come in at less than 7 per cent of sales, says Philippe Houchois at Jefferies....
...Public research, R&D tax incentives and research grants were the most cost-effective tools for governments to use, the research found....
...But it signals that the company is committed to returning cash to investors in the longer term....
...He argued that the size of an R&D budget was not an automatic guarantee of success. “Two of the companies that had the lowest R&D spending a decade ago were Eli Lilly and Novo Nordisk....
...The company has ramped up research spend. In the last fiscal year, R&D costs were equal to 7.8 per cent of revenue, up from 3.3 per cent in 2014....
...Advantech launched a software R&D centre in Pune last October and aims to hire hundreds of software engineers....
...To change this, European companies themselves must invest in growth. US corporates spend roughly twice what European companies do on capex and R&D (as a share of cash flow)....
...He says Vertex’s $4.8bn R&D budget is not about maximising “shots on goal”; it is instead focused on “a set number” of diseases where Vertex has “super-high conviction that they’re going to work”....
...The company on Friday said it planned to invest close to €7bn on R&D this year, up from about €5.5bn in 2020....
...The company also receives a US R&D tax credit. Across the US, the effective tax rate paid by large profitable companies is far lower than the statutory rate....
International Edition